Description

SEBI announces the completion of Recovery Certificate No. RC9065 of 2026 against Ayusri Health Products Limited (formerly Sahul India Limited, PAN: AADCS7349J) in the matter of Illiquid Stock Options, signifying successful recovery of dues.

Summary

SEBI has issued a notice confirming the completion of Recovery Certificate No. RC9065 of 2026 against Ayusri Health Products Limited (previously known as Sahul India Limited), bearing PAN AADCS7349J, in the matter of Illiquid Stock Options. This notice marks the successful conclusion of the recovery proceedings initiated against the entity for its role in the Illiquid Stock Options case.

Key Points

  • Recovery Certificate No. RC9065 of 2026 has been marked as completed against Ayusri Health Products Limited.
  • The company was previously known as Sahul India Limited (PAN: AADCS7349J).
  • The recovery pertains to SEBI’s enforcement action in the matter of manipulation of Illiquid Stock Options, primarily on BSE.
  • Completion of the recovery certificate indicates that the outstanding dues/penalties have been recovered from the entity.
  • This forms part of SEBI’s broader enforcement drive against entities involved in the Illiquid Stock Options manipulation case.

Regulatory Changes

No new regulatory changes are introduced by this notice. It is an administrative order confirming the closure of an enforcement recovery action.

Compliance Requirements

  • No new compliance requirements are imposed on the market by this notice.
  • The named entity (Ayusri Health Products Limited / Sahul India Limited) has fulfilled its financial obligations under the recovery certificate.
  • Other entities with open recovery certificates in the Illiquid Stock Options matter should continue to cooperate with SEBI’s recovery proceedings.

Important Dates

  • Recovery Certificate: RC9065 of 2026
  • Completion Date: March 23, 2026
  • The original enforcement action relates to SEBI’s ongoing proceedings in the Illiquid Stock Options matter.

Impact Assessment

The impact of this notice is limited to the named entity. It signals the closure of SEBI’s financial recovery action against Ayusri Health Products Limited (formerly Sahul India Limited) and has no direct bearing on broader market operations or other market participants. Investors in the company may note that this enforcement-related financial liability has been resolved. The notice is part of SEBI’s systematic enforcement and recovery drive in the widespread Illiquid Stock Options manipulation case that involved multiple entities on the BSE platform.

Impact Justification

This is an administrative completion notice for a recovery proceeding against a specific entity. The recovery has already been completed, so there is no forward-looking regulatory change or broad market impact. Relevant primarily to the named entity and its investors.